1. Home
  2. PYCR vs BLCO Comparison

PYCR vs BLCO Comparison

Compare PYCR & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYCR
  • BLCO
  • Stock Information
  • Founded
  • PYCR 1990
  • BLCO 1853
  • Country
  • PYCR United States
  • BLCO Canada
  • Employees
  • PYCR N/A
  • BLCO N/A
  • Industry
  • PYCR Computer Software: Prepackaged Software
  • BLCO Ophthalmic Goods
  • Sector
  • PYCR Technology
  • BLCO Health Care
  • Exchange
  • PYCR Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • PYCR 4.1B
  • BLCO 4.0B
  • IPO Year
  • PYCR 2021
  • BLCO 2022
  • Fundamental
  • Price
  • PYCR N/A
  • BLCO $12.06
  • Analyst Decision
  • PYCR Buy
  • BLCO Hold
  • Analyst Count
  • PYCR 16
  • BLCO 12
  • Target Price
  • PYCR $20.97
  • BLCO $18.64
  • AVG Volume (30 Days)
  • PYCR 2.9M
  • BLCO 939.1K
  • Earning Date
  • PYCR 05-07-2025
  • BLCO 04-30-2025
  • Dividend Yield
  • PYCR N/A
  • BLCO N/A
  • EPS Growth
  • PYCR N/A
  • BLCO N/A
  • EPS
  • PYCR N/A
  • BLCO N/A
  • Revenue
  • PYCR $699,733,000.00
  • BLCO $4,791,000,000.00
  • Revenue This Year
  • PYCR $14.26
  • BLCO $6.30
  • Revenue Next Year
  • PYCR $11.45
  • BLCO $5.56
  • P/E Ratio
  • PYCR N/A
  • BLCO N/A
  • Revenue Growth
  • PYCR 15.72
  • BLCO 15.56
  • 52 Week Low
  • PYCR $10.92
  • BLCO $10.46
  • 52 Week High
  • PYCR $23.49
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • PYCR 1.06
  • BLCO 38.44
  • Support Level
  • PYCR $22.34
  • BLCO $11.62
  • Resistance Level
  • PYCR $22.52
  • BLCO $12.38
  • Average True Range (ATR)
  • PYCR 0.06
  • BLCO 0.89
  • MACD
  • PYCR -2.27
  • BLCO -0.03
  • Stochastic Oscillator
  • PYCR 0.00
  • BLCO 37.74

About PYCR Paycor HCM Inc.

Paycor HCM provides payroll and human capital management solutions to small and midsize clients in the United States via a software-as-a-service model. Alongside core payroll functionality, the firm's platform offers a suite of HCM solutions including talent management and time and attendance software, third-party integration capabilities, and industry-specific configurations. The firm targets customers with 10-1,000 employees and had over 30,500 customers as of June 2024.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: